{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:21:21Z","timestamp":1786436481641,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,7,21]],"date-time":"2009-07-21T00:00:00Z","timestamp":1248134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s12640-009-9090-5","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T18:14:16Z","timestamp":1248113656000},"page":"130-141","source":"Crossref","is-referenced-by-count":158,"title":["Valproic Acid is Neuroprotective in the Rotenone Rat Model of Parkinson\u2019s Disease: Involvement of \u03b1-Synuclein"],"prefix":"10.1007","volume":"17","author":[{"given":"Barbara","family":"Monti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Piretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta S.","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Virgili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Contestabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,21]]},"reference":[{"key":"9090_CR1","doi-asserted-by":"crossref","first-page":"50980","DOI":"10.1074\/jbc.M207825200","volume":"277","author":"C Alves Da Costa","year":"2002","unstructured":"Alves Da Costa C, Paitel E, Vincent B, Checler F (2002) Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson\u2019s disease. J Biol Chem 277:50980\u201350984","journal-title":"J Biol Chem"},{"key":"9090_CR2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3:1301\u20131306","journal-title":"Nat Neurosci"},{"key":"9090_CR3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nurt.2006.11.007","volume":"4","author":"M Bialer","year":"2007","unstructured":"Bialer M, Yagen B (2007) Valproic acid: second generation. Neurotherapeutics 4:130\u2013137","journal-title":"Neurotherapeutics"},{"key":"9090_CR4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-5618.2003.00031.x","volume":"5","author":"CL Bowden","year":"2003","unstructured":"Bowden CL (2003) Valproate. Bipol Disord. 5:189\u2013202","journal-title":"Bipol Disord."},{"key":"9090_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(99)00100-3","volume":"230","author":"L Caruccio","year":"1999","unstructured":"Caruccio L, Banerjee R (1999) An efficient method for simultaneous isolation of biologically active transcription factors and DNA. J Immunol Methods 230:1\u201310","journal-title":"J Immunol Methods"},{"key":"9090_CR6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","volume":"11","author":"PS Chen","year":"2006","unstructured":"Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, Wilson B, Lu RB, Gean PW, Chuang DM, Hong JS (2006) Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11:1116\u20131125","journal-title":"Mol Psychiatry"},{"key":"9090_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2007.06.053","volume":"149","author":"PS Chen","year":"2007","unstructured":"Chen PS, Wang CC, Bortner CD, Peng GS, Wu X, Pang H, Lu RB, Gean PW, Chuang DM, Hong JS (2007) Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 149:203\u2013212","journal-title":"Neuroscience"},{"key":"9090_CR8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1196\/annals.1344.018","volume":"1053","author":"DM Chuang","year":"2005","unstructured":"Chuang DM (2005) The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann N Y Acad Sci 1053:195\u2013204","journal-title":"Ann N Y Acad Sci"},{"key":"9090_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.09.088","volume":"1247","author":"A D\u2019Souza","year":"2009","unstructured":"D\u2019Souza A, Onem E, Patel P, La Gamma EF, Nankova BB (2009) Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation. Brain Res 1247:1\u201310","journal-title":"Brain Res"},{"key":"9090_CR10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molbrainres.2005.09.002","volume":"142","author":"M DeCastro","year":"2005","unstructured":"DeCastro M, Nankova BB, Shah P, Patel P, Mally PV, Mishra R, La Gamma EF (2005) Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway. Mol Brain Res 142:28\u201338","journal-title":"Mol Brain Res"},{"key":"9090_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9013-5","volume":"15","author":"S Eleuteri","year":"2009","unstructured":"Eleuteri S, Monti B, Brignani S, Contestabile A (2009) Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity. Neurotox Res 15:127\u2013132","journal-title":"Neurotox Res"},{"key":"9090_CR12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4161\/auto.5604","volume":"4","author":"S Engelender","year":"2008","unstructured":"Engelender S (2008) Ubiquitination of alpha-synuclein and autophagy in Parkinson\u2019s disease. Autophagy 4:372\u2013374","journal-title":"Autophagy"},{"key":"9090_CR13","first-page":"288","volume":"22","author":"Y Feng","year":"2006","unstructured":"Feng Y, Liang ZH, Wang T, Qiao X, Liu HJ, Sun SG (2006) Alpha-synuclein redistributed and aggregated in rotenone-induced Parkinson\u2019s disease rats. Neurosci Bull 22:288\u2013293","journal-title":"Neurosci Bull"},{"key":"9090_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2005.01.004","volume":"86","author":"KN Fountoulakis","year":"2005","unstructured":"Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS (2005) Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 86:1\u201310","journal-title":"J Affect Disord"},{"key":"9090_CR15","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1021\/bi0341152","volume":"42","author":"J Goers","year":"2003","unstructured":"Goers J, Manning-Bog AB, McCormack AL, Millett IS, Doniach S, Di Monte DA, Uversky VN, Fink AL (2003) Nuclear localization of alpha-synuclein and its interaction with histones. Biochemistry 42:8465\u20138671","journal-title":"Biochemistry"},{"key":"9090_CR16","first-page":"S91","volume":"83","author":"M G\u00f6ttlicher","year":"2004","unstructured":"G\u00f6ttlicher M (2004) Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. Ann Hematol 83:S91\u2013S92","journal-title":"Ann Hematol"},{"key":"9090_CR17","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher M, Minucci S, Zhu P, Kr\u00e4mer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG, Heinzel T (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969\u20136978","journal-title":"EMBO J"},{"key":"9090_CR18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0021-9673(01)95999-0","volume":"541","author":"G Grossi","year":"1991","unstructured":"Grossi G, Bargossi AM, Lucarelli C, Paradisi R, Sprovieri C, Sprovieri G (1991) Improvements in automated analysis of catecholamines and related metabolites in biological samples by column-switching high-performance liquid chromatography. J Chromatogr 541:273\u2013284","journal-title":"J Chromatogr"},{"key":"9090_CR19","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1523\/JNEUROSCI.5747-03.2004","volume":"24","author":"Y Hao","year":"2004","unstructured":"Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P, Gould TD, Manji HK, Chen G (2004) Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci 24:6590\u20136599","journal-title":"J Neurosci"},{"key":"9090_CR20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/35056583","volume":"2","author":"L Hicke","year":"2001","unstructured":"Hicke L (2001) Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2:195\u2013201","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9090_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1471-4159.2003.01835.x","volume":"86","author":"PJ Jensen","year":"2003","unstructured":"Jensen PJ, Alter BJ, O\u2019Malley KL (2003) Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. J Neurochem 86:196\u2013209","journal-title":"J Neurochem"},{"key":"9090_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-5793(03)00350-8","volume":"542","author":"MR Jeong","year":"2003","unstructured":"Jeong MR, Hashimoto R, Senatorov VV, Fujimaki K, Ren M, Lee MS, Chuang DM (2003) Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett 542:74\u201378","journal-title":"FEBS Lett"},{"issue":"3","key":"9090_CR23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","volume":"321","author":"HJ Kim","year":"2007","unstructured":"Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM (2007) Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 321(3):892\u2013901","journal-title":"J Pharmacol Exp Ther"},{"key":"9090_CR24","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","volume":"22","author":"D Kirik","year":"2002","unstructured":"Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ, Bj\u00f6rklund A (2002) Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci 22:2780\u20132791","journal-title":"J Neurosci"},{"key":"9090_CR25","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","volume":"15","author":"E Kontopoulos","year":"2006","unstructured":"Kontopoulos E, Parvin JD, Feany MB (2006) Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet 15:3012\u20133023","journal-title":"Hum Mol Genet"},{"key":"9090_CR26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M, K\u00f6sel S, Przuntek H, Epplen JT, Sch\u00f6ls L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108","journal-title":"Nat Genet"},{"key":"9090_CR27","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","volume":"26","author":"Y Leng","year":"2006","unstructured":"Leng Y, Chuang DM (2006) Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J Neurosci 26:7502\u20137512","journal-title":"J Neurosci"},{"key":"9090_CR28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2003.09.075","volume":"354","author":"WL Lin","year":"2004","unstructured":"Lin WL, DeLucia MW, Dickson DW (2004) Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy. Neurosci Lett 354:99\u2013102","journal-title":"Neurosci Lett"},{"key":"9090_CR29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","volume":"16","author":"W L\u00f6scher","year":"2002","unstructured":"L\u00f6scher W (2002) Basic pharmacology of valproate: a review after 35\u00a0years of clinical use for the treatment of epilepsy. CNS Drugs 16:669\u2013694","journal-title":"CNS Drugs"},{"key":"9090_CR30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosenbrough RJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"9090_CR31","first-page":"27","volume":"60","author":"HK Manji","year":"1999","unstructured":"Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G (1999) Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J Clin Psychiatry 60:27\u201339","journal-title":"J Clin Psychiatry"},{"key":"9090_CR32","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1523\/JNEUROSCI.23-08-03095.2003","volume":"23","author":"AB Manning-Bog","year":"2003","unstructured":"Manning-Bog AB, McCormack AL, Purisai MG, Bolin LM, Di Monte DA (2003) Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J Neurosci 23:3095\u20133099","journal-title":"J Neurosci"},{"key":"9090_CR33","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804\u20132815","journal-title":"J Neurosci"},{"key":"9090_CR34","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265\u20131269","journal-title":"Science"},{"key":"9090_CR35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","volume":"8","author":"Y Matsuoka","year":"2001","unstructured":"Matsuoka Y, Vila M, Lincoln S, McCormack A, Picciano M, LaFrancois J, Yu X, Dickson D, Langston WJ, McGowan E, Farrer M, Hardy J, Duff K, Przedborski S, Di Monte DA (2001) Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis 8:535\u2013539","journal-title":"Neurobiol Dis"},{"key":"9090_CR36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0006-3223(94)00117-L","volume":"37","author":"SL McElroy","year":"1995","unstructured":"McElroy SL, Keck PE (1995) Misattribution of eating and obsessive-compulsive disorder symptoms to repressed memories of childhood sexual or physical abuse. Biol Psychiatry 37:48\u201351","journal-title":"Biol Psychiatry"},{"key":"9090_CR37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.nbd.2008.10.001","volume":"33","author":"BH Meurers","year":"2008","unstructured":"Meurers BH, Zhu C, Fernagut PO, Richter F, Hsia YC, Fleming SM, Oh M, Elashoff D, Dicarlo CD, Seaman RL, Chesselet MF (2008) Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo. Neurobiol Dis 33:182\u2013192","journal-title":"Neurobiol Dis"},{"key":"9090_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-8993(03)03456-5","volume":"992","author":"B Monti","year":"2003","unstructured":"Monti B, Contestabile A (2003) Selective alteration of DNA fragmentation and caspase activity in the spinal cord of aged rats and effect of dietary restriction. Brain Res 992:137\u2013141","journal-title":"Brain Res"},{"key":"9090_CR39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1471-4159.2007.04778.x","volume":"103","author":"B Monti","year":"2007","unstructured":"Monti B, Polazzi E, Batti L, Crochemore C, Virgili M, Contestabile A (2007) Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death. J Neurochem 103:518\u2013530","journal-title":"J Neurochem"},{"key":"9090_CR40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1874467210902010095","volume":"2","author":"B Monti","year":"2009","unstructured":"Monti B, Polazzi E, Contestabile A (2009) Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2:95\u2013109","journal-title":"Curr Mol Pharmacol"},{"issue":"11","key":"9090_CR41","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/01.WCB.0000138666.25305.A7","volume":"24","author":"C Morland","year":"2004","unstructured":"Morland C, Boldingh KA, Iversen EG, Hassel B (2004) Valproate is neuroprotective against malonate toxicity in rat striatum: an association with augmentation of high-affinity glutamate uptake. J Cereb Blood Flow Metab 24(11):1226\u20131234","journal-title":"J Cereb Blood Flow Metab"},{"key":"9090_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0070-2153(04)60002-0","volume":"60","author":"EH Norris","year":"2004","unstructured":"Norris EH, Giasson BI, Lee VM (2004) Alpha-synuclein: normal function and role in neurodegenerative diseases. Curr Top Dev Biol 60:17\u201354","journal-title":"Curr Top Dev Biol"},{"key":"9090_CR43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0317167100023970","volume":"6","author":"J Nutt","year":"1979","unstructured":"Nutt J, Williams A, Plotkin C, Eng N, Ziegler M, Calne DB (1979) Treatment of Parkinson\u2019s disease with sodium valproate: clinical, pharmacological, and biochemical observations. Can J Neurol Sci 6:337\u2013343","journal-title":"Can J Neurol Sci"},{"key":"9090_CR44","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1016\/j.febslet.2005.10.067","volume":"579","author":"T Pan","year":"2005","unstructured":"Pan T, Li X, Xie W, Jankovic J, Le W (2005) Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells. FEBS Lett 579:6716\u20136720","journal-title":"FEBS Lett"},{"key":"9090_CR45","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734\u201336741","journal-title":"J Biol Chem"},{"key":"9090_CR46","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"9090_CR47","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/jnnp.41.8.702","volume":"41","author":"PA Price","year":"1978","unstructured":"Price PA, Parkes JD, Marsden CD (1978) Sodium valproate in the treatment of levodopa-induced dyskinesia. J Neurol Neurosurg Psychiatr 41:702\u2013706","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"9090_CR48","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1046\/j.1471-4159.2001.00366.x","volume":"77","author":"S Rathke-Hartlieb","year":"2001","unstructured":"Rathke-Hartlieb S, Kahle PJ, Neumann M, Ozmen L, Haid S, Okochi M, Haass C, Schulz JB (2001) Sensitivity to MPTP is not increased in Parkinson\u2019s disease-associated mutant alpha-synuclein transgenic mice. J Neurochem 77:1181\u20131184","journal-title":"J Neurochem"},{"key":"9090_CR49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","volume":"5","author":"MA Rogawski","year":"2004","unstructured":"Rogawski MA, L\u00f6scher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5:553\u2013564","journal-title":"Nat Rev Neurosci"},{"key":"9090_CR50","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1074\/jbc.M704809200","volume":"283","author":"R Rott","year":"2008","unstructured":"Rott R, Szargel R, Haskin J, Shani V, Shainskaya A, Manov I, Liani E, Avraham E, Engelender S (2008) Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells. J Biol Chem 283:3316\u20133328","journal-title":"J Biol Chem"},{"key":"9090_CR51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc2145","volume":"7","author":"L Salmena","year":"2007","unstructured":"Salmena L, Pandolfi PP (2007) Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation. Nat Rev Cancer 7:409\u2013413","journal-title":"Nat Rev Cancer"},{"key":"9090_CR52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0893-133X(99)00072-X","volume":"22","author":"SA Sands","year":"2000","unstructured":"Sands SA, Guerra V, Morilak DA (2000) Changes in tyrosine hydroxylase mRNA expression in the rat locus coeruleus following acute or chronic treatment with valproic acid. Neuropsychopharmacology 22:27\u201335","journal-title":"Neuropsychopharmacology"},{"key":"9090_CR53","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1096\/fj.02-0041fje","volume":"16","author":"JH Seo","year":"2002","unstructured":"Seo JH, Rah JC, Choi SH, Shin JK, Min K, Kim HS, Park CH, Kim S, Kim EM, Lee SH, Lee S, Suh SW, Suh YH (2002) Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3\/Akt kinase pathway. FASEB J 16:1826\u20131828","journal-title":"FASEB J"},{"key":"9090_CR54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","volume":"179","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Kim JH, Betarbet R, Greenamyre JT (2003a) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 179:9\u201316","journal-title":"Exp Neurol"},{"key":"9090_CR55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(03)00172-1","volume":"341","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Kim JH, Greenamyre JT (2003b) Selective microglial activation in the rat rotenone model of Parkinson\u2019s disease. Neurosci Lett 341:87\u201390","journal-title":"Neurosci Lett"},{"key":"9090_CR56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.nbd.2007.02.006","volume":"26","author":"DI Sinn","year":"2007","unstructured":"Sinn DI, Kim SJ, Chu K, Jung KH, Lee ST, Song EC, Kim JM, Park DK, Kun Lee S, Kim M, Roh JK (2007) Valproic acid- mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol Dis 26:464\u2013472","journal-title":"Neurobiol Dis"},{"key":"9090_CR57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.cdd.4400816","volume":"8","author":"LD White","year":"2001","unstructured":"White LD, Barone S Jr (2001) Qualitative and quantitative estimates of apoptosis from birth to senescence in the rat brain. Cell Death Differ 8:345\u2013356","journal-title":"Cell Death Differ"},{"key":"9090_CR58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","volume":"91","author":"M Yamada","year":"2004","unstructured":"Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H (2004) Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease. J Neurochem 91:451\u2013461","journal-title":"J Neurochem"},{"key":"9090_CR59","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1440-1789.2007.00841.x","volume":"27","author":"M Yoshida","year":"2007","unstructured":"Yoshida M (2007) Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology 27:484\u2013493","journal-title":"Neuropathology"},{"key":"9090_CR60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuroscience.2006.12.028","volume":"145","author":"S Yu","year":"2007","unstructured":"Yu S, Li X, Liu G, Han J, Zhang C, Li Y, Xu S, Liu C, Gao Y, Yang H, U\u00e9da K, Chan P (2007) Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145:539\u2013555","journal-title":"Neuroscience"},{"key":"9090_CR61","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atar\u00e9s B, Llorens V, Gomez Tortosa E, del Ser T, Mu\u00f1oz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164\u2013173","journal-title":"Ann Neurol"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9090-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-009-9090-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9090-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T21:34:19Z","timestamp":1633728859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-009-9090-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,21]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["9090"],"URL":"https:\/\/doi.org\/10.1007\/s12640-009-9090-5","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,21]]}}}